Fig. 1

Experimental design. Comparing differences between ischemic and hemorrhagic moyamoya disease (MMD) patients using RNA sequencing and mass cytometry. PBMCs, peripheral blood mononuclear cells; NK, natural killer; DCs, dendritic cells